Tuberc Respir Dis.  2019 Apr;82(2):166-172. 10.4046/trd.2018.0065.

Association between Medical Costs and the ProVent Model in Patients Requiring Prolonged Mechanical Ventilation

• Roh J
• Shin MJ
• Jeong ES
• Lee K

• KMID: 2453987
• DOI: http://doi.org/10.4046/trd.2018.0065

Abstract

BACKGROUND
The purpose of this study was to determine whether components of the ProVent model can predict the high medical costs in Korean patients requiring at least 21 days of mechanical ventilation (prolonged mechanical ventilation [PMV]).
METHODS
Retrospective data from 302 patients (61.6% male; median age, 63.0 years) who had received PMV in the past 5 years were analyzed. To determine the relationship between medical cost per patient and components of the ProVent model, we collected the following data on day 21 of mechanical ventilation (MV): age, blood platelet count, requirement for hemodialysis, and requirement for vasopressors.
RESULTS
The mortality rate in the intensive care unit (ICU) was 31.5%. The average medical costs per patient during ICU and total hospital (ICU and general ward) stay were 35,105 and 41,110 US dollars (USD), respectively. The following components of the ProVent model were associated with higher medical costs during ICU stay: age <50 years (average 42,731 USD vs. 33,710 USD, p=0.001), thrombocytopenia on day 21 of MV (36,237 USD vs. 34,783 USD, p=0.009), and requirement for hemodialysis on day 21 of MV (57,864 USD vs. 33,509 USD, p<0.001). As the number of these three components increased, a positive correlation was found betweeen medical costs and ICU stay based on the Pearson's correlation coefficient (γ) (γ=0.367, p<0.001).
CONCLUSION
The ProVent model can be used to predict high medical costs in PMV patients during ICU stay. The highest medical costs were for patients who required hemodialysis on day 21 of MV.

Keyword

Costs; Mechanical Ventilation; Intensive Care Units

MeSH Terms

Humans
Intensive Care Units
Male
Mortality
Platelet Count
Renal Dialysis
Respiration, Artificial*
Retrospective Studies
Thrombocytopenia

Reference

1. Nelson JE, Cox CE, Hope AA, Carson SS. Chronic critical illness. Am J Respir Crit Care Med. 2010; 182:446–454. PMID: 20448093.

2. MacIntyre NR, Epstein SK, Carson S, Scheinhorn D, Christopher K, Muldoon S, et al. Management of patients requiring prolonged mechanical ventilation: report of a NAMDRC consensus conference. Chest. 2005; 128:3937–3954. PMID: 16354866.

3. Carson SS. Outcomes of prolonged mechanical ventilation. Curr Opin Crit Care. 2006; 12:405–411. PMID: 16943717.

4. Donahoe MP. Current venues of care and related costs for the chronically critically ill. Respir Care. 2012; 57:867–886. PMID: 22663964.

5. Cox CE, Carson SS, Govert JA, Chelluri L, Sanders GD. An economic evaluation of prolonged mechanical ventilation. Crit Care Med. 2007; 35:1918–1927. PMID: 17581479.

6. Carson SS, Garrett J, Hanson LC, Lanier J, Govert J, Brake MC, et al. A prognostic model for one-year mortality in patients requiring prolonged mechanical ventilation. Crit Care Med. 2008; 36:2061–2069. PMID: 18552692.

7. Carson SS, Kahn JM, Hough CL, Seeley EJ, White DB, Douglas IS, et al. A multicenter mortality prediction model for patients receiving prolonged mechanical ventilation. Crit Care Med. 2012; 40:1171–1176. PMID: 22080643.

8. Leroy G, Devos P, Lambiotte F, Thevenin D, Leroy O. One-year mortality in patients requiring prolonged mechanical ventilation: multicenter evaluation of the ProVent score. Crit Care. 2014; 18:R155. PMID: 25037939.

9. Mok JH, Kim YH, Jeong ES, Eom JS, Kim MH, Kim KU, et al. Clinical application of the ProVent score in Korean patients requiring prolonged mechanical ventilation: a 10-year experience in a university-affiliated tertiary hospital. J Crit Care. 2016; 33:158–162. PMID: 26994779.

10. Acute Respiratory Distress Syndrome Network. Brower RG, Matthay MA, Morris A, Schoenfeld D, Thompson BT, et al. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med. 2000; 342:1301–1308. PMID: 10793162.

11. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987; 40:373–383. PMID: 3558716.

12. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985; 13:818–829. PMID: 3928249.

13. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996; 22:707–710. PMID: 8844239.

14. Kim WY, Jo EJ, Eom JS, Mok J, Kim MH, Kim KU, et al. Validation of the Prognosis for Prolonged Ventilation (ProVent) score in patients receiving 14days of mechanical ventilation. J Crit Care. 2018; 44:249–254. PMID: 29202432.

15. Kim JH, Hong SK, Kim KC, Lee MG, Lee KM, Jung SS, et al. Influence of full-time intensivist and the nurse-to-patient ratio on the implementation of severe sepsis bundles in Korean intensive care units. J Crit Care. 2012; 27:414.e11–414.e21.

16. Kwak SH, Jeong CW, Lee SH, Lee HJ, Koh Y. Current status of intensive care units registered as critical care subspecialty training hospitals in Korea. J Korean Med Sci. 2014; 29:431–437. PMID: 24616595.

17. Lim CM, Kwak SH, Suh GY, Koh Y. Critical care in Korea: present and future. J Korean Med Sci. 2015; 30:1540–1544. PMID: 26538995.

18. Phua J, Joynt GM, Nishimura M, Deng Y, Myatra SN, Chan YH, et al. Withholding and withdrawal of life-sustaining treatments in intensive care units in Asia. JAMA Intern Med. 2015; 175:363–371. PMID: 25581712.